MDMA Dose Safety: What the Research Actually Shows
What clinical trials gave people, why we don't recommend a dose, and why non-linear pharmacokinetics make more MDMA riskier than the number suggests.
May 14, 2026 · Jordan Mercer
Contents
We don’t recommend an MDMA dose. Street MDMA has no reliable strength, people respond differently, and no study has tested a safe recreational amount. What we can tell you is what controlled research actually gave people, and why more MDMA is riskier than the arithmetic suggests: MDMA saturates the enzyme that clears it, so blood levels climb faster than the milligrams do. If you use, the safest pattern is the same regardless of the number: test it, weigh it, start with a small amount, and don’t redose.
What the trials actually gave people
The most tightly controlled MDMA dosing data in existence comes from the MAPS Phase 3 PTSD trials, published by Mitchell and colleagues in Nature Medicine in 2021. The protocol was:
- Session 1: 80 mg, plus a 40 mg supplemental dose 1.5 to 2.5 hours later
- Sessions 2 and 3: 120 mg, plus a 60 mg supplemental dose
Evidence tier: clinical trial. These doses were given under medical supervision to people with severe PTSD, some of them with cardiovascular risk factors, and the adverse effect profile was judged acceptable.
The anchor that gives you is not “120 mg is safe.” It’s that 80 to 120 mg is where the effect the researchers wanted showed up without unacceptable harm, in a quiet room, with a doctor, no alcohol, no dancing, and nothing else in the drug. A recreational setting adds every variable the trial was designed to remove.
Why we don’t give a weight-based number
You will see weight-based formulas for MDMA elsewhere. None has been tested in a trial. They borrow the general idea that drug effect scales with body mass, but MDMA’s effect also depends on liver genetics, temperature, what else you’ve taken and what’s actually in the pill, none of which a formula can see. A precise-looking number from a formula gives false confidence, so we don’t publish one.
What the research does support is direction, not a target. Less MDMA means less cardiovascular strain, less overheating risk and a gentler adverse-effect curve. For a first experience, or any new batch, take a small amount and wait. You can always take more later. You cannot undo having taken too much.
A weighed dose or a guessed one
Any amount is meaningless if you are eyeballing powder. Most people are much worse at estimating a small pile of powder than they believe, and the error runs both directions.
Look for a scale with 0.001 g (1 mg) readability and included calibration weights, and actually calibrate it. These scales drift, and they arrive uncalibrated more often than not. A milligram scale from DanceSafe is the difference between the amount you meant to take and twice it.
Be honest about what a cheap scale can do. Readability is not accuracy. A budget 0.001 g scale is genuinely unreliable below roughly 10 to 20 mg, which makes it workable for powders weighed in tens of milligrams and badly suited to anything measured in single milligrams. For substances active in micrograms, like LSD, a milligram scale cannot help you at all. Those need volumetric dosing: dissolve a known quantity in a known volume of liquid, then measure the liquid.
Capsules are a delivery format, not a measuring tool. Capping powder makes a weighed dose easier to swallow, hides the taste, and stops you casually adding a bit more mid-session. It does not make the dose accurate. Weigh first, then fill. Gelatin capsules are standard; vegetarian capsules made from cellulose behave identically once swallowed. A standard capsule holds far more powder than anyone should take at once, so capsule size is never the constraint.
One thing worth knowing: a capsule delays onset by roughly 10 to 20 minutes compared to bare powder. That delay is exactly the window in which people decide nothing is happening and redose. See why an MDMA dose can fail to land.
Doubling the dose does not double the blood level
This is the concept most dosing guides skate over, and it’s the reason more MDMA is riskier than it looks.
De la Torre and colleagues showed in the British Journal of Clinical Pharmacology in 2000 that MDMA has non-linear, saturable pharmacokinetics. As the dose goes up, plasma concentration rises disproportionately. Going from 75 mg to 150 mg is not a doubling of blood levels, it’s a much steeper climb, because MDMA saturates CYP2D6, the liver enzyme that metabolises it, and inhibits its own breakdown. The authors noted plainly that this makes subjects more prone to acute toxicity from what look like modest increases.
A 2004 pharmacology study extended the point: after two consecutive doses, MDMA causes mechanism-based inhibition of CYP2D6, so everyone starts behaving like a poor metaboliser regardless of their genetics. Poor metabolisers reach considerably higher plasma levels from the same dose. That is why redosing is riskier than the milligram arithmetic implies, and part of why some nights turn unexpectedly intense or unexpectedly long.
Hyperthermia, cardiovascular strain and serotonin toxicity all track this curve. Higher doses are not simply stronger.
You cannot tell a pill by looking at it
Drug checking data compiled by Palamar and colleagues found pressed tablets ranging from no MDMA at all to more than 240 mg in a single pill. One normal-looking tablet may hold more than twice as much as another from the same batch. Tablets are also often mixed unevenly, so half a pill is not reliably half the dose.
Then there is what else is in it. Drug checking regularly turns up methamphetamine, which produces similar stimulation with a much longer half-life and worse neurotoxicity; synthetic cathinones like methylone and MDPV, with unpredictable duration and a narrower margin; and fentanyl, confirmed in MDMA samples at multiple festival checking operations and lethal at microgram doses.
Use a fentanyl test strip alongside the reagents on anything pressed. Read the strip as one line POSITIVE, two lines NEGATIVE, which is the opposite of what nearly everyone assumes on first look. Test every batch, not just the first one. Our drug testing guide has the full protocol.
Redosing
The safest redose is none. If you do anyway:
- Once only. The curve for euphoria flattens with repeated doses. The curve for adverse effects does not.
- Smaller than the first. It lands in a body that hasn’t cleared the first dose, with the clearing enzyme already partly disabled.
- Not during the come-up. Peak blood levels land around 1.5 to 2 hours after an oral dose. Redosing earlier stacks on top of a first dose that is still rising.
- Remember MDA. MDMA partly metabolises into MDA, which has a longer half-life and peaks later. When you redose, MDA from the first dose is still building, so the true load is higher than the total you took suggests.
For context on what research has tested: the trial protocol above gave a supplemental dose of half the first, 1.5 to 2.5 hours later, under medical supervision. A 2026 trial tested that pattern and found it extended the experience by about an hour without a stronger peak. More in why redosing stops working.
Why the same dose lands differently
Genetics. Roughly 5 to 10 percent of people of European descent are CYP2D6 poor metabolisers and clear MDMA much more slowly, reaching higher plasma levels from an identical dose. You cannot know this about yourself without genetic testing, which is one more argument for starting low.
Temperature. MDMA impairs thermoregulation, and MDMA-related deaths are disproportionately associated with hyperthermia rather than isolated cardiac events. Hot rooms, hard dancing and no breaks are a dosing variable even though they aren’t measured in milligrams.
What else is on board. MAOIs and MDMA can produce fatal serotonin syndrome. Other serotonergic drugs, including several antidepressants, amplify serotonin toxicity risk. Stimulants compound cardiovascular strain. Check the interaction checker before mixing anything.
Water. Too little and too much are both dangerous. MDMA promotes water retention, and drinking large volumes of plain water can drop blood sodium to a life-threatening level, a risk that falls disproportionately on women. Around 500 mL per hour while dancing, with electrolytes. If you are sitting down, drink to thirst.
If it’s your first time
Test it first. Weigh it, and take a small amount. Do not redose, because a single dose is the only way to learn what a single dose does to you. Stay cool, keep electrolytes in the water, and have someone with you who knows what you took and would call for help without hesitating.
How much you take is the most controllable variable in this whole picture and the one most often skipped over. Tested, weighed, a small amount, taken once, in a room you can leave when it gets hot: that is the lowest-risk version of this available.
For the wider picture, see the MDMA guide.
Sources
PMID 33972795 | PMID 10671903 | PMID 15228154 | PMID 21320226